Since receiving his degree in engineering, Heinz Jacqui has held several positions in the field of medical technology in a career spanning more than 30 years. As Global Business Unit President of Dräger Medical, he oversaw the Critical Care, Architectural Systems and Neonatal Care divisions. Working from Shanghai, for four years Jacqui managed the China trade for Dräger Medical. His next steps led him to Olympus Medical, where, as Executive Vice President, he was responsible for the global laparoscopy business. Following this position, Jacqui was named President & CEO at Maquet/Getinge, where he oversaw the global medicine business.
“We are very pleased to have recruited Heinz Jacqui as Senior Advisor for SHS,” SHS Managing Partner Hubertus Leonhardt remarked. “His many years of strategic experience with companies in the field of medical technology have made him a true asset to us and our portfolio companies. Together, we want to offer strategic support to our portfolio firms, particularly in the fields of cardiology, imaging and intensive-care medicine and review investments in additional firms.”
“SHS has an exciting spread of portfolio companies with strong growth. I look forward to assisting, on a case-by-case basis, with strategic orientation and the initiation of international cooperation arrangements with corporate groups in the medical-technology sector,” Heinz Jacqui noted. “I’m also excited to help explore and evaluate additional investments under the recently launched SHS V fund.”
SHS Gesellschaft für Beteiligungsmanagement is based in Tuebingen, Germany, and invests in medical technology and life science companies with a focus on expansion financing, changes in shareholder structures and successor situations. SHS holds minority as well as majority interests. The company was founded in 1993 and has since gained extensive experience as an industry investor which supports the growth of its portfolio companies through a network of partnerships regarding the introduction of new products, regulatory issues or entering new markets. The SHS fund’s European based investors include pension funds, strategic investors, funds of funds, family offices, entrepreneurs and the SHS management team. The AIFM-registered company invests up to €30 million in equity capital and volumes exceeding this amount are implemented with a network of co-investors. SHS is currently investing from its fifth fund which received capital commitments of more than €130 million. Further information: http://www.shs-capital.eu/en/
Are you interested in receiving regular updates about SHS? Subscribe to our newsletter!
http://www.shs-capital.eu/en/newsletter/
SHS Gesellschaft für Beteiligungsmanagement mbH
Bismarckstraße 12
72072 Tuebingen
Telefon: +49 (7071) 9169-0
Telefax: +49 (7071) 9169-190
http://www.shs-capital.eu/
SHS Gesellschaft für Beteiligungsmanagement mbH
E-Mail: tuebingen@shs-capital.eu